Q2 2024 Holdings
Filed 2024-08-14 | 44 holdings | $643.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cullinan Therapeutics, Inc.(CGEM) | Common | 230031106 | $133.4M | 7,648,268 | 20.7% |
| Insmed Incorporated(INSM) | Common | 457669307 | $41.2M | 615,391 | 6.4% |
| Olema Pharmaceuticals, Inc.(OLMA) | Common | 68062P106 | $28.7M | 2,654,867 | 4.5% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $25.9M | 1,745,943 | 4.0% |
| Crinetics Pharmaceuticals Inc.(CRNX) | Common | 22663K107 | $25.0M | 557,184 | 3.9% |
| Madrigal Pharmaceuticals inc(MDGL) | Common | 558868105 | $19.9M | 71,185 | 3.1% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $19.0M | 2,366,714 | 2.9% |
| Natera Inc(NTRA) | Common | 632307104 | $18.9M | 174,811 | 2.9% |
| Mirum Pharmaceuticals Inc(MIRM) | Common | 604749101 | $16.8M | 492,569 | 2.6% |
| Ultragenyx Pharmaceutical Inc(RARE) | Common | 90400D108 | $15.6M | 380,552 | 2.4% |
| Moonlake Immunotherapeutics(MLTX) | Class A Ord | 61559X104 | $15.1M | 343,235 | 2.3% |
| Guardant Health Inc(GH) | Common | 40131M109 | $14.4M | 500,000 | 2.2% |
| Disc Medicine Inc(IRON) | Common | 254604101 | $13.8M | 305,658 | 2.1% |
| Alkermes Plc(ALKS) | Common | G01767105 | $13.4M | 557,556 | 2.1% |
| Edgewise Therapeutics Inc(EWTX) | Common | 28036F105 | $13.3M | 740,661 | 2.1% |
| ALX Oncology Holdings Inc.(ALXO) | Common | 00166B105 | $13.2M | 2,180,864 | 2.0% |
| Morphic Holding Inc | Common | 61775R105 | $12.6M | 369,384 | 2.0% |
| Lantheus Holdings Inc(LNTH) | Common | 516544103 | $12.0M | 150,000 | 1.9% |
| Revolution Medicines, Inc.(RVMD) | Common | 76155X100 | $11.2M | 289,396 | 1.7% |
| Avadel Pharmaceuticals PLC | Sponsored ADR | 05337M104 | $11.0M | 783,242 | 1.7% |
| Xeris Biopharma Holdings Inc(XERS) | Common | 98422E103 | $10.9M | 4,830,526 | 1.7% |
| Axsome Therapeutics, Inc.(AXSM) | Common | 05464T104 | $10.7M | 132,312 | 1.7% |
| Kalvista Pharmaceuticals Inc(KALV) | Common | 483497103 | $10.4M | 881,937 | 1.6% |
| Intellia Therapeutics, Inc.(NTLA) | Common | 45826J105 | $9.9M | 443,503 | 1.5% |
| Hillevax Inc | Common | 43157M102 | $9.3M | 645,085 | 1.4% |
| Akero Therapeutics Inc(AKRO) | Common | 00973Y108 | $9.1M | 385,990 | 1.4% |
| 89Bio Inc(ETNBGBP) | Common | 282559103 | $9.0M | 1,121,736 | 1.4% |
| Fulcrum Therapeutics Inc(FULC) | Common | 359616109 | $9.0M | 1,444,851 | 1.4% |
| Sutro Biopharma, Inc. | Common | 869367102 | $8.9M | 3,043,346 | 1.4% |
| Scholar Rock Holding Corp(SRRK) | Common | 80706P103 | $8.6M | 1,028,330 | 1.3% |
| Relay Therapeutics Inc.(RLAY) | Common | 75943R102 | $8.3M | 1,274,459 | 1.3% |
| Cartesian Therapeutics Inc(RNAC) | Common | 816212302 | $7.0M | 259,696 | 1.1% |
| Regenxbio Inc.(RGNX) | Common | 75901B107 | $6.5M | 557,076 | 1.0% |
| Viking Therapeutics Inc(VKTX) | Common | 92686J106 | $6.3M | 118,960 | 1.0% |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | Common | 98943L107 | $5.9M | 1,450,000 | 0.9% |
| Werewolf Therapeutics, Inc.(HOWL) | Common | 95075A107 | $5.8M | 2,388,011 | 0.9% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $5.4M | 1,639,849 | 0.8% |
| Avidity Biosciences Inc(RNA) | Common | 05370A108 | $5.1M | 125,000 | 0.8% |
| Compass Therapeutics, Inc.(CMPX) | Common | 20454B104 | $5.0M | 5,005,086 | 0.8% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $5.0M | 5,095,912 | 0.8% |
| Immatics NV(IMTX) | Common | N44445109 | $4.9M | 417,810 | 0.8% |
| Trevi Therapeutics Inc(TRVI) | Common | 89532M101 | $4.5M | 1,510,174 | 0.7% |
| Verve Therapeutics, Inc | Common | 92539P101 | $3.1M | 638,163 | 0.5% |
| Allakos(ALLKGUSD) | Common | 01671P100 | $344.9K | 344,900 | 0.1% |